Bridge Biotherapeutics, Inc. (KOSDAQ:288330)
South Korea
· Delayed Price · Currency is KRW
6,080.00
-20.00 (-0.33%)
At close: Mar 21, 2025, 3:30 PM KST
Bridge Biotherapeutics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Apr '25 Apr 2, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 384,428 | 162,383 | 80,182 | 277,059 | - | - | |
| Market Cap Growth | 102.52% | 102.52% | -71.06% | - | - | - | |
| Enterprise Value | 367,168 | 142,417 | 57,779 | 218,889 | - | - | |
| Last Close Price | 7730.00 | 3750.00 | 2386.14 | 8425.95 | 10314.52 | 10568.76 | |
| Forward PE | - | 9.41 | 9.41 | 9.41 | 9.41 | 9.41 | |
| PS Ratio | 74553.55 | 74553.55 | 801.82 | 91.63 | - | - | |
| PB Ratio | 15.00 | 5.89 | 3.87 | 5.34 | - | - | |
| P/TBV Ratio | 7.94 | 7.94 | 6.78 | 5.61 | - | - | |
| EV/Sales Ratio | 65386.56 | 65386.56 | 577.79 | 72.39 | - | - | |
| Debt / Equity Ratio | 0.10 | 0.10 | 0.17 | 0.06 | 0.01 | 0.01 | |
| Asset Turnover | 0 | 0 | 0.00 | 0.06 | 0.04 | 0.09 | |
| Quick Ratio | 5.70 | 5.70 | 2.01 | 6.97 | 12.23 | 56.55 | |
| Current Ratio | 6.03 | 6.03 | 2.09 | 7.33 | 12.49 | 57.14 | |
| Return on Equity (ROE) | -82.55% | -82.55% | -116.97% | -87.87% | -51.39% | -28.65% | |
| Return on Assets (ROA) | -35.09% | -35.09% | -52.72% | -50.30% | -29.95% | -17.08% | |
| Return on Capital (ROIC) | -43.63% | -43.63% | -63.73% | -55.40% | -32.06% | -18.15% | |
| Earnings Yield | -5.14% | -12.17% | -52.78% | -15.05% | - | - | |
| FCF Yield | -5.39% | -12.76% | -40.03% | -14.66% | - | - | |
| Buyback Yield / Dilution | -10.79% | -35.81% | -25.99% | -1.56% | -2.53% | -96.53% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.